Compare MOV & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOV | NBY |
|---|---|---|
| Founded | 1961 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.7M | 398.2M |
| IPO Year | 1993 | 2007 |
| Metric | MOV | NBY |
|---|---|---|
| Price | $22.35 | $2.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | 132.8K | ★ 2.2M |
| Earning Date | 11-25-2025 | 11-07-2025 |
| Dividend Yield | ★ 6.19% | N/A |
| EPS Growth | ★ 27.72 | N/A |
| EPS | ★ 0.97 | 0.47 |
| Revenue | ★ $661,205,000.00 | $10,302,000.00 |
| Revenue This Year | $2.19 | $23.91 |
| Revenue Next Year | $0.89 | $32.05 |
| P/E Ratio | ★ $23.31 | $92.21 |
| Revenue Growth | 2.78 | ★ 390.34 |
| 52 Week Low | $12.85 | $0.46 |
| 52 Week High | $23.06 | $19.95 |
| Indicator | MOV | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 55.22 | 38.23 |
| Support Level | $22.14 | $1.80 |
| Resistance Level | $22.91 | $18.40 |
| Average True Range (ATR) | 0.66 | 3.07 |
| MACD | -0.05 | -1.35 |
| Stochastic Oscillator | 50.35 | 1.10 |
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.